作者: Martin A. Folger , Stefan Lehner
DOI:
关键词:
摘要: The invention relates to novel liquid preparation comprising a substituted benzimidazol, preferably pimobendan as pharmaceutically active compound. In particular, the present an etherified cyclodextrin derivative, in concentration of about 20 70% (w/v) and 5 said 0.005 0.15 % (w/w).